Resveratrol and breast cancer chemoprevention: molecular mechanisms.
about
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidenceResveratrol: a review of preclinical studies for human cancer preventionRoles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer MetastasisImpact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerResveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell linesStabilization of resveratrol in blood circulation by conjugation to mPEG and mPEG-PLA polymers: investigation of conjugate linker and polymer composition on stability, metabolism, antioxidant activity and pharmacokinetic profileApoptotic Cell Death Induced by Resveratrol Is Partially Mediated by the Autophagy Pathway in Human Ovarian Cancer CellsDifferences in the tumor microenvironment between African-American and European-American breast cancer patientsCharacterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR).Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats.Resveratrol and cancer: focus on in vivo evidence.Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.Structure-function correlation of G6, a novel small molecule inhibitor of Jak2: indispensability of the stilbenoid core.Resveratrol, MicroRNAs, Inflammation, and Cancer.The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis.The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo.Acetylation and nuclear receptor actionAcetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor.Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomasThe Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.Immortalization of epithelial progenitor cells mediated by resveratrol.Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesisDerailed estrogen signaling and breast cancer: an authentic couple.Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat.The functional significance of nuclear receptor acetylationCombined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model.Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice.Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes.Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer.Cancer chemoprevention by polyphenols and their potential application as nanomedicine.Cell death pathway induced by resveratrol-bovine serum albumin nanoparticles in a human ovarian cell line.Anticancer Activity of Stilbene-Based Derivatives.Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?
P2860
Q24618313-D4383B07-C61B-4A77-AFE5-BB8C942A9581Q24675163-9BB69A4C-73E0-4096-BCCC-80666025304FQ26745561-9AA2AE3F-F97B-4A2F-B508-BF02E6589B84Q27016123-7BA4A005-ED08-4F09-A6F1-EFB19E6054ABQ28477048-2AE43205-0D62-42A2-8A0C-CD11A6C5C4DAQ28544851-5F33E5F4-A7E9-4DAE-A528-2D8796300B66Q28548163-2A43BDC2-A6EB-4EFA-801B-B6726697BEF0Q33410258-4A5EBC44-E47E-4517-A966-73CC4FD001DFQ33482542-0FEFD0C0-EF49-43A8-A00D-6499934ADC99Q33554013-1BD79C20-2277-443F-B676-82D0679CC7DEQ33578943-126C8F1A-0659-45AB-9095-E0E4EF9915E3Q34010001-C69DDE92-E98E-49B5-8C30-6CFBE66CCCB8Q34181360-70DBA342-0B5C-41E0-A2C5-323B37946F13Q34208358-B3209206-22FE-4E18-944D-FE7E8E7852E4Q34337681-BCDABB29-49B2-4E7B-9651-D816ADEB4178Q34575802-0171D679-E7F6-4A88-ACF2-92375DB1B7F8Q34666075-68B229D4-73DC-4B0F-AEB1-71C0ECFD2FD4Q34698474-B03A8019-E733-4AAE-8D52-0A7A47B8428EQ35198394-4D696D50-20E3-4A06-ADAF-50A01ED6CE46Q35550085-9999E3EB-12F5-4587-B61B-47F703D0382FQ35571892-16E1D2D5-0131-468F-B08A-3DA55E75B889Q35955076-BA8A83C3-CC9A-47A1-BDE8-164722875865Q36095883-3E9035DD-9118-4E75-B1D8-BD14A0C956E2Q36466614-307CD0B7-2CE3-4331-B036-FFB9C4B0799DQ36589361-FEF3FCC5-F211-408C-AA5A-C71C0C353CA3Q36689118-4A2A2E5A-8D4A-4EA9-8055-060C493AA089Q36732771-A165737A-F8E1-4666-A91B-905F44CABFC1Q36831357-F785C5A6-4358-440D-827B-652EAF6BF077Q36871537-140C62A8-E2A9-49E4-A71C-269BD7A3AB56Q37141380-BF08F474-F3C1-4F34-BF7F-BBC900AD16CAQ37184771-E53105A7-E3BA-472B-B808-09AEAD3FC37AQ37227343-6435A216-7D8F-416F-8FD1-231A27FA2394Q37715501-EC740584-C26F-48E5-830F-1BBE11D11D76Q37780645-10CEBC93-5A7E-47F6-B80A-61C7093BF572Q37962472-2FB310B4-DB4F-43BA-927F-35416C4585AEQ38093653-A7696DBA-73AC-482A-BAB0-2E381DADADB6Q38911580-0A61D1A1-D59E-4199-A726-74BDEC1FF6BAQ39165544-1D3004A8-2D04-49C6-B26D-3C0305665749Q39383463-894767F2-7264-401F-83DB-E6241AB81B10Q39402269-34328275-6E96-4628-A8C7-D355365D79D1
P2860
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
@ast
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
@en
type
label
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
@ast
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
@en
prefLabel
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
@ast
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
@en
P2093
P2860
P356
P1476
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
@en
P2093
D J Bernard-Gallon
Ludovic Le Corre
Yves-Jean Bignon
P2860
P304
P356
10.1002/MNFR.200400094
P577
2005-05-01T00:00:00Z